Planned website maintenance is taking place from 11:00 pm AEDT on Friday 30 October to 6:00 am AEDT on Saturday 31 October 2026. Some pages may be temporarily unavailable. If issues continue outside this time, please contact us.
Capvaxive
Australian Public Assessment Report
Device/Product Name
Capvaxive
Active ingredients
Pneumococcal 21-valent Conjugate Vaccine
AusPAR Date
Published
Submission Number
PM-2023-05219-1-2
Submission Type
New biological entity
Decision
Approved